Chengdu Easton Biopharmaceuticals Co., Ltd. Class ASSE: 688513

Announcement on Voluntary Disclosure of Prospective Winning in the National Centralized Drug Procurement

· Issued by Chengdu Easton Biopharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Prospective Winning in the National Centralized Drug Procurement

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment